nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP2C8—Pazopanib—kidney cancer	0.102	0.158	CbGbCtD
Secobarbital—CYP1A2—Pazopanib—kidney cancer	0.0788	0.123	CbGbCtD
Secobarbital—CYP2C9—Capecitabine—kidney cancer	0.074	0.115	CbGbCtD
Secobarbital—CYP2C8—Erlotinib—kidney cancer	0.0726	0.113	CbGbCtD
Secobarbital—CYP2C8—Paclitaxel—kidney cancer	0.0665	0.104	CbGbCtD
Secobarbital—CYP2C8—Sorafenib—kidney cancer	0.059	0.092	CbGbCtD
Secobarbital—CYP1A2—Erlotinib—kidney cancer	0.0562	0.0875	CbGbCtD
Secobarbital—CYP2C9—Paclitaxel—kidney cancer	0.0464	0.0722	CbGbCtD
Secobarbital—CYP1A2—Sorafenib—kidney cancer	0.0457	0.0712	CbGbCtD
Secobarbital—CYP2C9—Sorafenib—kidney cancer	0.0412	0.0641	CbGbCtD
Secobarbital—Hypoxia—Gemcitabine—kidney cancer	0.00478	0.0188	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Temsirolimus—kidney cancer	0.00468	0.0184	CcSEcCtD
Secobarbital—Hepatocellular injury—Everolimus—kidney cancer	0.00453	0.0178	CcSEcCtD
Secobarbital—Hepatocellular injury—Erlotinib—kidney cancer	0.00437	0.0172	CcSEcCtD
Secobarbital—Respiratory failure—Sunitinib—kidney cancer	0.00385	0.0151	CcSEcCtD
Secobarbital—Depressed level of consciousness—Sunitinib—kidney cancer	0.00365	0.0143	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Everolimus—kidney cancer	0.00348	0.0137	CcSEcCtD
Secobarbital—Respiratory failure—Vincristine—kidney cancer	0.00326	0.0128	CcSEcCtD
Secobarbital—Respiratory failure—Gemcitabine—kidney cancer	0.00309	0.0121	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Sorafenib—kidney cancer	0.00302	0.0119	CcSEcCtD
Secobarbital—Injection site reaction—Gemcitabine—kidney cancer	0.00302	0.0119	CcSEcCtD
Secobarbital—Bradycardia—Pazopanib—kidney cancer	0.00293	0.0115	CcSEcCtD
Secobarbital—Thinking abnormal—Paclitaxel—kidney cancer	0.00277	0.0109	CcSEcCtD
Secobarbital—Respiratory failure—Paclitaxel—kidney cancer	0.00259	0.0102	CcSEcCtD
Secobarbital—Injection site reaction—Paclitaxel—kidney cancer	0.00252	0.00992	CcSEcCtD
Secobarbital—Angioedema—Temsirolimus—kidney cancer	0.00243	0.00955	CcSEcCtD
Secobarbital—Hallucination—Everolimus—kidney cancer	0.00226	0.00889	CcSEcCtD
Secobarbital—Anxiety—Temsirolimus—kidney cancer	0.00226	0.00887	CcSEcCtD
Secobarbital—Syncope—Pazopanib—kidney cancer	0.00225	0.00883	CcSEcCtD
Secobarbital—Mental disability—Paclitaxel—kidney cancer	0.0022	0.00866	CcSEcCtD
Secobarbital—Loss of consciousness—Pazopanib—kidney cancer	0.0022	0.00866	CcSEcCtD
Secobarbital—Ataxia—Vincristine—kidney cancer	0.00218	0.00858	CcSEcCtD
Secobarbital—Injection site reaction—Capecitabine—kidney cancer	0.00207	0.00814	CcSEcCtD
Secobarbital—Depressed level of consciousness—Capecitabine—kidney cancer	0.00201	0.00791	CcSEcCtD
Secobarbital—Shock—Pazopanib—kidney cancer	0.00201	0.00791	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Paclitaxel—kidney cancer	0.00195	0.00768	CcSEcCtD
Secobarbital—Bradycardia—Sunitinib—kidney cancer	0.00193	0.0076	CcSEcCtD
Secobarbital—Somnolence—Temsirolimus—kidney cancer	0.00193	0.00758	CcSEcCtD
Secobarbital—Constipation—Temsirolimus—kidney cancer	0.00186	0.0073	CcSEcCtD
Secobarbital—Agitation—Everolimus—kidney cancer	0.00182	0.00715	CcSEcCtD
Secobarbital—Somnolence—Pazopanib—kidney cancer	0.00182	0.00715	CcSEcCtD
Secobarbital—Mental disability—Capecitabine—kidney cancer	0.00181	0.00711	CcSEcCtD
Secobarbital—Angioedema—Everolimus—kidney cancer	0.00181	0.0071	CcSEcCtD
Secobarbital—Syncope—Everolimus—kidney cancer	0.00177	0.00697	CcSEcCtD
Secobarbital—Loss of consciousness—Everolimus—kidney cancer	0.00174	0.00683	CcSEcCtD
Secobarbital—Ataxia—Paclitaxel—kidney cancer	0.00173	0.00681	CcSEcCtD
Secobarbital—Body temperature increased—Temsirolimus—kidney cancer	0.00172	0.00674	CcSEcCtD
Secobarbital—Syncope—Erlotinib—kidney cancer	0.00171	0.00673	CcSEcCtD
Secobarbital—Anxiety—Everolimus—kidney cancer	0.00168	0.0066	CcSEcCtD
Secobarbital—Loss of consciousness—Erlotinib—kidney cancer	0.00168	0.00659	CcSEcCtD
Secobarbital—Anxiety—Erlotinib—kidney cancer	0.00162	0.00637	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Capecitabine—kidney cancer	0.0016	0.0063	CcSEcCtD
Secobarbital—Hypersensitivity—Temsirolimus—kidney cancer	0.0016	0.00629	CcSEcCtD
Secobarbital—Hallucination—Vincristine—kidney cancer	0.0016	0.00628	CcSEcCtD
Secobarbital—Liver injury—Doxorubicin—kidney cancer	0.0016	0.00627	CcSEcCtD
Secobarbital—Shock—Everolimus—kidney cancer	0.00159	0.00624	CcSEcCtD
Secobarbital—Angioedema—Sorafenib—kidney cancer	0.00157	0.00617	CcSEcCtD
Secobarbital—Syncope—Sorafenib—kidney cancer	0.00154	0.00605	CcSEcCtD
Secobarbital—Shock—Erlotinib—kidney cancer	0.00153	0.00602	CcSEcCtD
Secobarbital—Angioedema—Sunitinib—kidney cancer	0.00151	0.00593	CcSEcCtD
Secobarbital—Loss of consciousness—Sorafenib—kidney cancer	0.00151	0.00593	CcSEcCtD
Secobarbital—Hypotension—Everolimus—kidney cancer	0.00151	0.00593	CcSEcCtD
Secobarbital—Thinking abnormal—Doxorubicin—kidney cancer	0.00147	0.00577	CcSEcCtD
Secobarbital—Somnolence—Everolimus—kidney cancer	0.00144	0.00564	CcSEcCtD
Secobarbital—Dizziness—Temsirolimus—kidney cancer	0.00144	0.00564	CcSEcCtD
Secobarbital—Ataxia—Capecitabine—kidney cancer	0.00142	0.00559	CcSEcCtD
Secobarbital—Constipation—Vinblastine—kidney cancer	0.00139	0.00545	CcSEcCtD
Secobarbital—Constipation—Everolimus—kidney cancer	0.00138	0.00543	CcSEcCtD
Secobarbital—Vomiting—Temsirolimus—kidney cancer	0.00138	0.00542	CcSEcCtD
Secobarbital—Shock—Sorafenib—kidney cancer	0.00138	0.00542	CcSEcCtD
Secobarbital—Rash—Temsirolimus—kidney cancer	0.00137	0.00538	CcSEcCtD
Secobarbital—Dermatitis—Temsirolimus—kidney cancer	0.00137	0.00537	CcSEcCtD
Secobarbital—Headache—Temsirolimus—kidney cancer	0.00136	0.00534	CcSEcCtD
Secobarbital—Dizziness—Pazopanib—kidney cancer	0.00135	0.00531	CcSEcCtD
Secobarbital—Hepatocellular injury—Doxorubicin—kidney cancer	0.00134	0.00528	CcSEcCtD
Secobarbital—Feeling abnormal—Vinblastine—kidney cancer	0.00134	0.00525	CcSEcCtD
Secobarbital—Injection site reaction—Doxorubicin—kidney cancer	0.00134	0.00525	CcSEcCtD
Secobarbital—Constipation—Erlotinib—kidney cancer	0.00133	0.00524	CcSEcCtD
Secobarbital—Feeling abnormal—Everolimus—kidney cancer	0.00133	0.00523	CcSEcCtD
Secobarbital—Shock—Sunitinib—kidney cancer	0.00133	0.00521	CcSEcCtD
Secobarbital—Vomiting—Pazopanib—kidney cancer	0.0013	0.00511	CcSEcCtD
Secobarbital—Bradycardia—Paclitaxel—kidney cancer	0.0013	0.0051	CcSEcCtD
Secobarbital—Rash—Pazopanib—kidney cancer	0.00129	0.00507	CcSEcCtD
Secobarbital—Nausea—Temsirolimus—kidney cancer	0.00129	0.00507	CcSEcCtD
Secobarbital—Dermatitis—Pazopanib—kidney cancer	0.00129	0.00506	CcSEcCtD
Secobarbital—Agitation—Vincristine—kidney cancer	0.00128	0.00505	CcSEcCtD
Secobarbital—Headache—Pazopanib—kidney cancer	0.00128	0.00504	CcSEcCtD
Secobarbital—Body temperature increased—Everolimus—kidney cancer	0.00128	0.00502	CcSEcCtD
Secobarbital—Body temperature increased—Erlotinib—kidney cancer	0.00123	0.00484	CcSEcCtD
Secobarbital—Nausea—Pazopanib—kidney cancer	0.00121	0.00477	CcSEcCtD
Secobarbital—Constipation—Sorafenib—kidney cancer	0.0012	0.00471	CcSEcCtD
Secobarbital—Hypersensitivity—Vinblastine—kidney cancer	0.00119	0.00469	CcSEcCtD
Secobarbital—Hypersensitivity—Everolimus—kidney cancer	0.00119	0.00468	CcSEcCtD
Secobarbital—Mental disability—Doxorubicin—kidney cancer	0.00117	0.00458	CcSEcCtD
Secobarbital—Constipation—Sunitinib—kidney cancer	0.00115	0.00453	CcSEcCtD
Secobarbital—Body temperature increased—Sorafenib—kidney cancer	0.00111	0.00435	CcSEcCtD
Secobarbital—Tension—Paclitaxel—kidney cancer	0.00109	0.00428	CcSEcCtD
Secobarbital—Nervousness—Paclitaxel—kidney cancer	0.00108	0.00424	CcSEcCtD
Secobarbital—Dizziness—Vinblastine—kidney cancer	0.00107	0.00421	CcSEcCtD
Secobarbital—Dizziness—Everolimus—kidney cancer	0.00107	0.0042	CcSEcCtD
Secobarbital—Body temperature increased—Sunitinib—kidney cancer	0.00107	0.00419	CcSEcCtD
Secobarbital—Hypotension—Vincristine—kidney cancer	0.00107	0.00419	CcSEcCtD
Secobarbital—Bradycardia—Capecitabine—kidney cancer	0.00107	0.00419	CcSEcCtD
Secobarbital—Feeling abnormal—Dactinomycin—kidney cancer	0.00105	0.00414	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00103	0.00406	CcSEcCtD
Secobarbital—Hypersensitivity—Sorafenib—kidney cancer	0.00103	0.00406	CcSEcCtD
Secobarbital—Vomiting—Vinblastine—kidney cancer	0.00103	0.00405	CcSEcCtD
Secobarbital—Dizziness—Erlotinib—kidney cancer	0.00103	0.00405	CcSEcCtD
Secobarbital—Vomiting—Everolimus—kidney cancer	0.00103	0.00403	CcSEcCtD
Secobarbital—Agitation—Paclitaxel—kidney cancer	0.00102	0.00401	CcSEcCtD
Secobarbital—Rash—Everolimus—kidney cancer	0.00102	0.004	CcSEcCtD
Secobarbital—Dermatitis—Everolimus—kidney cancer	0.00102	0.004	CcSEcCtD
Secobarbital—Headache—Vinblastine—kidney cancer	0.00102	0.00399	CcSEcCtD
Secobarbital—Angioedema—Paclitaxel—kidney cancer	0.00101	0.00399	CcSEcCtD
Secobarbital—Headache—Everolimus—kidney cancer	0.00101	0.00398	CcSEcCtD
Secobarbital—Hypotension—Gemcitabine—kidney cancer	0.00101	0.00397	CcSEcCtD
Secobarbital—Body temperature increased—Dactinomycin—kidney cancer	0.00101	0.00397	CcSEcCtD
Secobarbital—Syncope—Paclitaxel—kidney cancer	0.000996	0.00391	CcSEcCtD
Secobarbital—Hypersensitivity—Sunitinib—kidney cancer	0.000994	0.00391	CcSEcCtD
Secobarbital—Vomiting—Erlotinib—kidney cancer	0.000991	0.00389	CcSEcCtD
Secobarbital—Rash—Erlotinib—kidney cancer	0.000982	0.00386	CcSEcCtD
Secobarbital—Dermatitis—Erlotinib—kidney cancer	0.000982	0.00386	CcSEcCtD
Secobarbital—Headache—Erlotinib—kidney cancer	0.000976	0.00384	CcSEcCtD
Secobarbital—Loss of consciousness—Paclitaxel—kidney cancer	0.000976	0.00383	CcSEcCtD
Secobarbital—Constipation—Vincristine—kidney cancer	0.000976	0.00383	CcSEcCtD
Secobarbital—Nausea—Vinblastine—kidney cancer	0.000963	0.00378	CcSEcCtD
Secobarbital—Somnolence—Gemcitabine—kidney cancer	0.000962	0.00378	CcSEcCtD
Secobarbital—Nausea—Everolimus—kidney cancer	0.000959	0.00377	CcSEcCtD
Secobarbital—Anxiety—Paclitaxel—kidney cancer	0.000942	0.0037	CcSEcCtD
Secobarbital—Hypersensitivity—Dactinomycin—kidney cancer	0.000941	0.0037	CcSEcCtD
Secobarbital—Dizziness—Sorafenib—kidney cancer	0.000927	0.00364	CcSEcCtD
Secobarbital—Constipation—Gemcitabine—kidney cancer	0.000926	0.00364	CcSEcCtD
Secobarbital—Nausea—Erlotinib—kidney cancer	0.000926	0.00364	CcSEcCtD
Secobarbital—Ataxia—Doxorubicin—kidney cancer	0.000917	0.0036	CcSEcCtD
Secobarbital—Confusional state—Paclitaxel—kidney cancer	0.000914	0.00359	CcSEcCtD
Secobarbital—Body temperature increased—Vincristine—kidney cancer	0.000902	0.00354	CcSEcCtD
Secobarbital—Dizziness—Sunitinib—kidney cancer	0.000892	0.00351	CcSEcCtD
Secobarbital—Feeling abnormal—Gemcitabine—kidney cancer	0.000892	0.0035	CcSEcCtD
Secobarbital—Shock—Paclitaxel—kidney cancer	0.000891	0.0035	CcSEcCtD
Secobarbital—Vomiting—Sorafenib—kidney cancer	0.000891	0.0035	CcSEcCtD
Secobarbital—Rash—Sorafenib—kidney cancer	0.000884	0.00347	CcSEcCtD
Secobarbital—Dermatitis—Sorafenib—kidney cancer	0.000883	0.00347	CcSEcCtD
Secobarbital—Headache—Sorafenib—kidney cancer	0.000878	0.00345	CcSEcCtD
Secobarbital—Vomiting—Sunitinib—kidney cancer	0.000858	0.00337	CcSEcCtD
Secobarbital—Body temperature increased—Gemcitabine—kidney cancer	0.000856	0.00336	CcSEcCtD
Secobarbital—Rash—Sunitinib—kidney cancer	0.00085	0.00334	CcSEcCtD
Secobarbital—Dermatitis—Sunitinib—kidney cancer	0.00085	0.00334	CcSEcCtD
Secobarbital—Hypotension—Paclitaxel—kidney cancer	0.000847	0.00333	CcSEcCtD
Secobarbital—Headache—Sunitinib—kidney cancer	0.000845	0.00332	CcSEcCtD
Secobarbital—Hypersensitivity—Vincristine—kidney cancer	0.000841	0.0033	CcSEcCtD
Secobarbital—Nausea—Sorafenib—kidney cancer	0.000833	0.00327	CcSEcCtD
Secobarbital—Syncope—Capecitabine—kidney cancer	0.000817	0.00321	CcSEcCtD
Secobarbital—Vomiting—Dactinomycin—kidney cancer	0.000812	0.00319	CcSEcCtD
Secobarbital—Somnolence—Paclitaxel—kidney cancer	0.000806	0.00317	CcSEcCtD
Secobarbital—Rash—Dactinomycin—kidney cancer	0.000805	0.00316	CcSEcCtD
Secobarbital—Nausea—Sunitinib—kidney cancer	0.000801	0.00315	CcSEcCtD
Secobarbital—Loss of consciousness—Capecitabine—kidney cancer	0.000801	0.00315	CcSEcCtD
Secobarbital—Constipation—Paclitaxel—kidney cancer	0.000775	0.00305	CcSEcCtD
Secobarbital—Anxiety—Capecitabine—kidney cancer	0.000773	0.00304	CcSEcCtD
Secobarbital—Nausea—Dactinomycin—kidney cancer	0.000758	0.00298	CcSEcCtD
Secobarbital—Dizziness—Vincristine—kidney cancer	0.000754	0.00296	CcSEcCtD
Secobarbital—Confusional state—Capecitabine—kidney cancer	0.00075	0.00295	CcSEcCtD
Secobarbital—Feeling abnormal—Paclitaxel—kidney cancer	0.000747	0.00293	CcSEcCtD
Secobarbital—Shock—Capecitabine—kidney cancer	0.000732	0.00287	CcSEcCtD
Secobarbital—Vomiting—Vincristine—kidney cancer	0.000725	0.00285	CcSEcCtD
Secobarbital—Rash—Vincristine—kidney cancer	0.000719	0.00283	CcSEcCtD
Secobarbital—Dermatitis—Vincristine—kidney cancer	0.000719	0.00282	CcSEcCtD
Secobarbital—Body temperature increased—Paclitaxel—kidney cancer	0.000716	0.00281	CcSEcCtD
Secobarbital—Headache—Vincristine—kidney cancer	0.000715	0.00281	CcSEcCtD
Secobarbital—Hypotension—Capecitabine—kidney cancer	0.000695	0.00273	CcSEcCtD
Secobarbital—Vomiting—Gemcitabine—kidney cancer	0.000688	0.0027	CcSEcCtD
Secobarbital—Bradycardia—Doxorubicin—kidney cancer	0.000687	0.0027	CcSEcCtD
Secobarbital—Rash—Gemcitabine—kidney cancer	0.000682	0.00268	CcSEcCtD
Secobarbital—Dermatitis—Gemcitabine—kidney cancer	0.000682	0.00268	CcSEcCtD
Secobarbital—Headache—Gemcitabine—kidney cancer	0.000678	0.00266	CcSEcCtD
Secobarbital—Nausea—Vincristine—kidney cancer	0.000678	0.00266	CcSEcCtD
Secobarbital—Hypersensitivity—Paclitaxel—kidney cancer	0.000668	0.00262	CcSEcCtD
Secobarbital—Nausea—Gemcitabine—kidney cancer	0.000643	0.00253	CcSEcCtD
Secobarbital—Constipation—Capecitabine—kidney cancer	0.000636	0.0025	CcSEcCtD
Secobarbital—Feeling abnormal—Capecitabine—kidney cancer	0.000613	0.00241	CcSEcCtD
Secobarbital—Dizziness—Paclitaxel—kidney cancer	0.000599	0.00235	CcSEcCtD
Secobarbital—Body temperature increased—Capecitabine—kidney cancer	0.000588	0.00231	CcSEcCtD
Secobarbital—Tension—Doxorubicin—kidney cancer	0.000576	0.00226	CcSEcCtD
Secobarbital—Vomiting—Paclitaxel—kidney cancer	0.000576	0.00226	CcSEcCtD
Secobarbital—Rash—Paclitaxel—kidney cancer	0.000571	0.00225	CcSEcCtD
Secobarbital—Dermatitis—Paclitaxel—kidney cancer	0.000571	0.00224	CcSEcCtD
Secobarbital—Nervousness—Doxorubicin—kidney cancer	0.00057	0.00224	CcSEcCtD
Secobarbital—Headache—Paclitaxel—kidney cancer	0.000568	0.00223	CcSEcCtD
Secobarbital—Hypersensitivity—Capecitabine—kidney cancer	0.000548	0.00215	CcSEcCtD
Secobarbital—Agitation—Doxorubicin—kidney cancer	0.00054	0.00212	CcSEcCtD
Secobarbital—Nausea—Paclitaxel—kidney cancer	0.000538	0.00212	CcSEcCtD
Secobarbital—Syncope—Doxorubicin—kidney cancer	0.000527	0.00207	CcSEcCtD
Secobarbital—Loss of consciousness—Doxorubicin—kidney cancer	0.000516	0.00203	CcSEcCtD
Secobarbital—Anxiety—Doxorubicin—kidney cancer	0.000498	0.00196	CcSEcCtD
Secobarbital—Dizziness—Capecitabine—kidney cancer	0.000492	0.00193	CcSEcCtD
Secobarbital—Confusional state—Doxorubicin—kidney cancer	0.000483	0.0019	CcSEcCtD
Secobarbital—Vomiting—Capecitabine—kidney cancer	0.000473	0.00186	CcSEcCtD
Secobarbital—Shock—Doxorubicin—kidney cancer	0.000472	0.00185	CcSEcCtD
Secobarbital—Rash—Capecitabine—kidney cancer	0.000469	0.00184	CcSEcCtD
Secobarbital—Dermatitis—Capecitabine—kidney cancer	0.000468	0.00184	CcSEcCtD
Secobarbital—Headache—Capecitabine—kidney cancer	0.000466	0.00183	CcSEcCtD
Secobarbital—Hypotension—Doxorubicin—kidney cancer	0.000448	0.00176	CcSEcCtD
Secobarbital—Nausea—Capecitabine—kidney cancer	0.000442	0.00174	CcSEcCtD
Secobarbital—Somnolence—Doxorubicin—kidney cancer	0.000426	0.00167	CcSEcCtD
Secobarbital—Constipation—Doxorubicin—kidney cancer	0.00041	0.00161	CcSEcCtD
Secobarbital—Feeling abnormal—Doxorubicin—kidney cancer	0.000395	0.00155	CcSEcCtD
Secobarbital—Body temperature increased—Doxorubicin—kidney cancer	0.000379	0.00149	CcSEcCtD
Secobarbital—Hypersensitivity—Doxorubicin—kidney cancer	0.000353	0.00139	CcSEcCtD
Secobarbital—Dizziness—Doxorubicin—kidney cancer	0.000317	0.00125	CcSEcCtD
Secobarbital—Vomiting—Doxorubicin—kidney cancer	0.000305	0.0012	CcSEcCtD
Secobarbital—Rash—Doxorubicin—kidney cancer	0.000302	0.00119	CcSEcCtD
Secobarbital—Dermatitis—Doxorubicin—kidney cancer	0.000302	0.00119	CcSEcCtD
Secobarbital—Headache—Doxorubicin—kidney cancer	0.0003	0.00118	CcSEcCtD
Secobarbital—Nausea—Doxorubicin—kidney cancer	0.000285	0.00112	CcSEcCtD
Secobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000103	0.000992	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—RAF1—kidney cancer	0.000102	0.000984	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTT1—kidney cancer	0.0001	0.000968	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—RAF1—kidney cancer	0.0001	0.000966	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTP1—kidney cancer	9.98e-05	0.000964	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.93e-05	0.00096	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	9.86e-05	0.000952	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	9.84e-05	0.000951	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.83e-05	0.00095	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—RAF1—kidney cancer	9.82e-05	0.000949	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	9.78e-05	0.000945	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	9.78e-05	0.000945	CbGpPWpGaD
Secobarbital—GABRA1—Ion channel transport—RAF1—kidney cancer	9.74e-05	0.000941	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.69e-05	0.000936	CbGpPWpGaD
Secobarbital—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	9.66e-05	0.000934	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—RAF1—kidney cancer	9.65e-05	0.000932	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	9.57e-05	0.000925	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.55e-05	0.000923	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.49e-05	0.000917	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—BRAF—kidney cancer	9.45e-05	0.000913	CbGpPWpGaD
Secobarbital—GRIK2—Neuronal System—MAPK1—kidney cancer	9.42e-05	0.00091	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	9.42e-05	0.00091	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	9.4e-05	0.000908	CbGpPWpGaD
Secobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	9.39e-05	0.000907	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—PTGS1—kidney cancer	9.39e-05	0.000907	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.38e-05	0.000906	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	9.31e-05	0.0009	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.22e-05	0.000891	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.22e-05	0.00089	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—BRAF—kidney cancer	9.18e-05	0.000887	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTM1—kidney cancer	9.17e-05	0.000886	CbGpPWpGaD
Secobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	9.12e-05	0.000881	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	9.12e-05	0.000881	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.06e-05	0.000875	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	9.05e-05	0.000874	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—BRAF—kidney cancer	9.01e-05	0.000871	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.99e-05	0.000869	CbGpPWpGaD
Secobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	8.96e-05	0.000866	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.9e-05	0.00086	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—BRAF—kidney cancer	8.86e-05	0.000856	CbGpPWpGaD
Secobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	8.81e-05	0.000851	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	8.76e-05	0.000846	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—RAF1—kidney cancer	8.73e-05	0.000844	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	8.7e-05	0.00084	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	8.69e-05	0.00084	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.68e-05	0.000839	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—BRAF—kidney cancer	8.64e-05	0.000835	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—RAF1—kidney cancer	8.62e-05	0.000833	CbGpPWpGaD
Secobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	8.59e-05	0.00083	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	8.58e-05	0.000829	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—MAPK1—kidney cancer	8.57e-05	0.000828	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.49e-05	0.00082	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.3e-05	0.000802	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.28e-05	0.0008	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	8.23e-05	0.000795	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.2e-05	0.000792	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	8.14e-05	0.000786	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTP1—kidney cancer	8.12e-05	0.000785	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	8.01e-05	0.000774	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—RAF1—kidney cancer	7.89e-05	0.000762	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.86e-05	0.000759	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—kidney cancer	7.82e-05	0.000755	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	7.72e-05	0.000746	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—RAF1—kidney cancer	7.66e-05	0.00074	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	7.65e-05	0.000739	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ACY1—kidney cancer	7.65e-05	0.000739	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.59e-05	0.000733	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—BRAF—kidney cancer	7.55e-05	0.00073	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—RAF1—kidney cancer	7.52e-05	0.000727	CbGpPWpGaD
Secobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	7.51e-05	0.000725	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.5e-05	0.000724	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	7.49e-05	0.000723	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTM1—kidney cancer	7.47e-05	0.000721	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—RAF1—kidney cancer	7.39e-05	0.000714	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	7.36e-05	0.000711	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	7.32e-05	0.000708	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.28e-05	0.000704	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—RAF1—kidney cancer	7.21e-05	0.000697	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—MAPK1—kidney cancer	7.2e-05	0.000696	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.15e-05	0.000691	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	7.08e-05	0.000684	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	7.06e-05	0.000682	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.03e-05	0.000679	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—MAPK1—kidney cancer	6.99e-05	0.000675	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	6.98e-05	0.000674	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTP1—kidney cancer	6.94e-05	0.000671	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	6.92e-05	0.000668	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.86e-05	0.000663	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.86e-05	0.000662	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	6.85e-05	0.000661	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.74e-05	0.000651	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.62e-05	0.00064	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.52e-05	0.00063	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PDHB—kidney cancer	6.5e-05	0.000628	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—POMC—kidney cancer	6.48e-05	0.000626	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.46e-05	0.000624	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTM1—kidney cancer	6.38e-05	0.000616	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—RAF1—kidney cancer	6.31e-05	0.000609	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	6.29e-05	0.000608	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ACY1—kidney cancer	6.23e-05	0.000601	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CCBL1—kidney cancer	6.11e-05	0.000591	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	6.05e-05	0.000584	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.99e-05	0.000579	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—MAPK1—kidney cancer	5.99e-05	0.000579	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	5.96e-05	0.000576	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—MAPK1—kidney cancer	5.92e-05	0.000571	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.64e-05	0.000545	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.53e-05	0.000534	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—MAPK1—kidney cancer	5.41e-05	0.000523	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ACY1—kidney cancer	5.32e-05	0.000514	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.31e-05	0.000513	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GLIPR1—kidney cancer	5.3e-05	0.000512	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PPAT—kidney cancer	5.3e-05	0.000512	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PDHB—kidney cancer	5.29e-05	0.000511	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—POMC—kidney cancer	5.28e-05	0.00051	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—MAPK1—kidney cancer	5.26e-05	0.000508	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.23e-05	0.000506	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.18e-05	0.000501	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—MAPK1—kidney cancer	5.16e-05	0.000499	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—MAPK1—kidney cancer	5.07e-05	0.00049	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CCBL1—kidney cancer	4.98e-05	0.000481	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—MAPK1—kidney cancer	4.95e-05	0.000478	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—FH—kidney cancer	4.93e-05	0.000476	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—APRT—kidney cancer	4.93e-05	0.000476	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.82e-05	0.000465	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	4.7e-05	0.000454	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	4.64e-05	0.000448	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GPC3—kidney cancer	4.63e-05	0.000448	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.54e-05	0.000438	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PDHB—kidney cancer	4.52e-05	0.000437	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—POMC—kidney cancer	4.51e-05	0.000436	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CA2—kidney cancer	4.51e-05	0.000436	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.5e-05	0.000435	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALAD—kidney cancer	4.39e-05	0.000424	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—MAPK1—kidney cancer	4.32e-05	0.000418	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PPAT—kidney cancer	4.31e-05	0.000417	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GLIPR1—kidney cancer	4.31e-05	0.000417	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ST3GAL2—kidney cancer	4.29e-05	0.000414	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.26e-05	0.000412	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CCBL1—kidney cancer	4.25e-05	0.000411	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	4.24e-05	0.00041	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.22e-05	0.000407	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALDH1A1—kidney cancer	4.19e-05	0.000405	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	4.12e-05	0.000398	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	4.05e-05	0.000391	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC5A3—kidney cancer	4.02e-05	0.000388	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PGK1—kidney cancer	4.02e-05	0.000388	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—APRT—kidney cancer	4.01e-05	0.000388	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—FH—kidney cancer	4.01e-05	0.000388	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.98e-05	0.000384	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—LDHB—kidney cancer	3.94e-05	0.000381	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.92e-05	0.000379	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.88e-05	0.000375	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.85e-05	0.000372	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GPC3—kidney cancer	3.77e-05	0.000364	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.69e-05	0.000356	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PPAT—kidney cancer	3.69e-05	0.000356	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CA2—kidney cancer	3.67e-05	0.000354	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.64e-05	0.000352	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.6e-05	0.000348	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALAD—kidney cancer	3.58e-05	0.000345	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ST3GAL2—kidney cancer	3.49e-05	0.000337	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—FH—kidney cancer	3.43e-05	0.000331	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—APRT—kidney cancer	3.43e-05	0.000331	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CA9—kidney cancer	3.42e-05	0.00033	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALDH1A1—kidney cancer	3.41e-05	0.00033	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.39e-05	0.000328	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.35e-05	0.000324	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.34e-05	0.000323	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PGK1—kidney cancer	3.27e-05	0.000316	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.27e-05	0.000316	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GPC3—kidney cancer	3.22e-05	0.000311	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—LDHB—kidney cancer	3.21e-05	0.00031	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CA2—kidney cancer	3.14e-05	0.000303	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALAD—kidney cancer	3.06e-05	0.000295	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.98e-05	0.000288	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.91e-05	0.000282	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CRABP1—kidney cancer	2.9e-05	0.000281	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.79e-05	0.00027	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PGK1—kidney cancer	2.79e-05	0.00027	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CA9—kidney cancer	2.78e-05	0.000269	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—LDHB—kidney cancer	2.74e-05	0.000265	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.72e-05	0.000263	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ITPR2—kidney cancer	2.7e-05	0.000261	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.49e-05	0.000241	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ACHE—kidney cancer	2.46e-05	0.000238	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTT1—kidney cancer	2.46e-05	0.000238	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CA9—kidney cancer	2.38e-05	0.00023	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CRABP1—kidney cancer	2.36e-05	0.000228	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SCARB1—kidney cancer	2.33e-05	0.000225	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.32e-05	0.000224	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTGS1—kidney cancer	2.31e-05	0.000223	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PSMD7—kidney cancer	2.26e-05	0.000219	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ITPR2—kidney cancer	2.2e-05	0.000212	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—BCHE—kidney cancer	2.15e-05	0.000207	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC5A5—kidney cancer	2.12e-05	0.000205	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC2A1—kidney cancer	2.05e-05	0.000198	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.03e-05	0.000196	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CRABP1—kidney cancer	2.02e-05	0.000195	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ACHE—kidney cancer	2e-05	0.000194	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTT1—kidney cancer	2e-05	0.000194	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.99e-05	0.000192	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SCARB1—kidney cancer	1.9e-05	0.000183	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ITPR2—kidney cancer	1.88e-05	0.000181	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTGS1—kidney cancer	1.88e-05	0.000181	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PSMD7—kidney cancer	1.84e-05	0.000178	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—BCHE—kidney cancer	1.75e-05	0.000169	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.73e-05	0.000167	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.73e-05	0.000167	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.72e-05	0.000167	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTT1—kidney cancer	1.71e-05	0.000165	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ACHE—kidney cancer	1.71e-05	0.000165	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTP1—kidney cancer	1.71e-05	0.000165	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.67e-05	0.000161	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SCARB1—kidney cancer	1.62e-05	0.000157	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.62e-05	0.000156	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCB1—kidney cancer	1.62e-05	0.000156	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTGS1—kidney cancer	1.61e-05	0.000155	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PSMD7—kidney cancer	1.57e-05	0.000152	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTM1—kidney cancer	1.57e-05	0.000152	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—BCHE—kidney cancer	1.49e-05	0.000144	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.49e-05	0.000144	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.47e-05	0.000142	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.42e-05	0.000138	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.41e-05	0.000136	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTP1—kidney cancer	1.39e-05	0.000134	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.38e-05	0.000133	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCB1—kidney cancer	1.32e-05	0.000127	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTM1—kidney cancer	1.28e-05	0.000123	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.22e-05	0.000118	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.21e-05	0.000117	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.2e-05	0.000116	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTP1—kidney cancer	1.19e-05	0.000115	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCB1—kidney cancer	1.12e-05	0.000109	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—POMC—kidney cancer	1.11e-05	0.000107	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTM1—kidney cancer	1.09e-05	0.000105	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.03e-05	9.99e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.94e-06	9.61e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—POMC—kidney cancer	9.02e-06	8.72e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTGS2—kidney cancer	8.84e-06	8.54e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.5e-06	8.21e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTEN—kidney cancer	7.71e-06	7.45e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—POMC—kidney cancer	7.71e-06	7.45e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTGS2—kidney cancer	7.2e-06	6.95e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTEN—kidney cancer	6.28e-06	6.06e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTGS2—kidney cancer	6.15e-06	5.94e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CA—kidney cancer	5.44e-06	5.26e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTEN—kidney cancer	5.36e-06	5.18e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.43e-06	4.28e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.78e-06	3.66e-05	CbGpPWpGaD
